These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 15744088)
1. Pharmacokinetics of chitobiose and chitotriose administered intravenously or orally to rats. Chen AS; Taguchi T; Okamoto H; Danjo K; Sakai K; Matahira Y; Wang MW; Miwa I Biol Pharm Bull; 2005 Mar; 28(3):545-8. PubMed ID: 15744088 [TBL] [Abstract][Full Text] [Related]
2. Effect of chitobiose and chitotriose on carbon tetrachloride-induced acute hepatotoxicity in rats. Chen AS; Taguchi T; Sakai K; Matahira Y; Wang MW; Miwa I Biol Pharm Bull; 2005 Oct; 28(10):1971-3. PubMed ID: 16204957 [TBL] [Abstract][Full Text] [Related]
3. Antioxidant activities of chitobiose and chitotriose. Chen AS; Taguchi T; Sakai K; Kikuchi K; Wang MW; Miwa I Biol Pharm Bull; 2003 Sep; 26(9):1326-30. PubMed ID: 12951480 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics, bioavailability and tissue distribution of chitobiose and chitotriose in rats. Chen M; Jin J; Ji X; Chang K; Li J; Zhao L Bioresour Bioprocess; 2022 Feb; 9(1):13. PubMed ID: 38647841 [TBL] [Abstract][Full Text] [Related]
5. Bactericidal activity of human lysozyme, muramidase-inactive lysozyme, and cationic polypeptides against Streptococcus sanguis and Streptococcus faecalis: inhibition by chitin oligosaccharides. Laible NJ; Germaine GR Infect Immun; 1985 Jun; 48(3):720-8. PubMed ID: 3922894 [TBL] [Abstract][Full Text] [Related]
6. Oral and intravenous trichloroethylene pharmacokinetics in the rat. D'Souza RW; Bruckner JV; Feldman S J Toxicol Environ Health; 1985; 15(5):587-601. PubMed ID: 4046066 [TBL] [Abstract][Full Text] [Related]
7. The absolute oral bioavailability and population-based pharmacokinetic modelling of a novel dipeptidylpeptidase-IV inhibitor, vildagliptin, in healthy volunteers. He YL; Sadler BM; Sabo R; Balez S; Wang Y; Campestrini J; Laurent A; Ligueros-Saylan M; Howard D Clin Pharmacokinet; 2007; 46(9):787-802. PubMed ID: 17713976 [TBL] [Abstract][Full Text] [Related]
8. Neural activity analysis of pure chito-oligomer components separated from a mixture of chitooligosaccharides. Jiang M; Guo Z; Wang C; Yang Y; Liang X; Ding F Neurosci Lett; 2014 Oct; 581():32-6. PubMed ID: 25128219 [TBL] [Abstract][Full Text] [Related]
9. The chbG gene of the chitobiose (chb) operon of Escherichia coli encodes a chitooligosaccharide deacetylase. Verma SC; Mahadevan S J Bacteriol; 2012 Sep; 194(18):4959-71. PubMed ID: 22797760 [TBL] [Abstract][Full Text] [Related]
10. Absorption, elimination, and metabolism of CS-1036, a novel α-amylase inhibitor in rats and monkeys, and the relationship between gastrointestinal distribution and suppression of glucose absorption. Honda T; Kaneno-Urasaki Y; Murai T; Kakuta M; Nasu H; Namba E; Koga T; Okuno A; Izumi T Drug Metab Dispos; 2013 Apr; 41(4):878-87. PubMed ID: 23378626 [TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetic model of human insulin following different routes of administration. Potocka E; Baughman RA; Derendorf H J Clin Pharmacol; 2011 Jul; 51(7):1015-24. PubMed ID: 20940337 [TBL] [Abstract][Full Text] [Related]
12. Intravenous pharmacokinetics, oral bioavailability and dose proportionality of ragaglitazar, a novel PPAR-dual activator in rats. Jagannath K; Chaluvadi MR; Mullangi R; Mamidi NV; Srinivas NR Biopharm Drug Dispos; 2004 Oct; 25(7):323-8. PubMed ID: 15386480 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of tulathromycin and its metabolite in swine administered with an intravenous bolus injection and a single gavage. Wang X; Tao YF; Huang LL; Chen DM; Yin SZ; Ihsan A; Zhou W; Su SJ; Liu ZL; Pan YH; Yuan ZH J Vet Pharmacol Ther; 2012 Jun; 35(3):282-9. PubMed ID: 21749408 [TBL] [Abstract][Full Text] [Related]
14. Oral bioavailability and pharmacokinetics of PAT-5A, a new insulin sensitizer in rats. Mamidi RN; Katneni K; Mullangi R; Ramanujam R Eur J Drug Metab Pharmacokinet; 2002; 27(3):175-8. PubMed ID: 12365198 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic properties of theophylline given intravenously and orally to ruminating calves. Langston VC; Koritz GD; Davis LE; Neff-Davis C Am J Vet Res; 1989 Apr; 50(4):493-7. PubMed ID: 2712416 [TBL] [Abstract][Full Text] [Related]
16. Absolute bioavailability, rate of absorption, and dose proportionality of sulpiride in humans. Bressolle F; Brès J; Fauré-Jeantis A J Pharm Sci; 1992 Jan; 81(1):26-32. PubMed ID: 1619566 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and lung tissue concentrations of tulathromycin in swine. Benchaoui HA; Nowakowski M; Sherington J; Rowan TG; Sunderland SJ J Vet Pharmacol Ther; 2004 Aug; 27(4):203-10. PubMed ID: 15305848 [TBL] [Abstract][Full Text] [Related]
18. Oral bioavailability and pharmacokinetics of DRF-4367, a new COX-2 inhibitor in rats. Ramesh M; Mamidi RN; Jagannath K; Singh SK; Rao KS; Rao YK; Seshagirirao C; Rajagopalan R; Srinivas NR Eur J Drug Metab Pharmacokinet; 2003; 28(2):137-41. PubMed ID: 12877572 [TBL] [Abstract][Full Text] [Related]
19. Evidence of a flip-flop phenomenon in acamprosate pharmacokinetics: an in vivo study in rats. Zornoza T; Cano-Cebrián MJ; Hipólito L; Granero L; Polache A Biopharm Drug Dispos; 2006 Oct; 27(7):305-11. PubMed ID: 16799924 [TBL] [Abstract][Full Text] [Related]
20. Comparative pharmacokinetics of purified flaxseed and associated mammalian lignans in male Wistar rats. Mukker JK; Singh RS; Muir AD; Krol ES; Alcorn J Br J Nutr; 2015 Mar; 113(5):749-57. PubMed ID: 25716060 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]